A multi-center validated diagnostic assay for VEGF detection utilizing gene engineering and monoclonal antibody technologies. Designed for comprehensive assessment of vascular endothelial growth factor in clinical settings for disease screening and monitoring.
Manufactured by
Beijing Jianping Jinxing Biomedical Co., Ltd
China
Beijing Jianping Jinxing Biomedical Co., Ltd. is a dual high-tech enterprise (National and Zhongguancun certified) specializing in IVD reagent raw materials preparation, R&D, manufacturing, and sales. The company focuses on Vascular Endothelial Growth Factor (VEGF) related in-vitro diagnostics, being the first globally to commercialize VEGF clinical applications and the only Chinese manufacturer with independent VEGF detection reagent raw material R&D and production capabilities.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GESIM Gesellschaft für Silizium-Mikrosysteme mbH
Germany · 2 relevant products
Guangdong Ascendas Genomics Technology Co., Ltd.
China · 2 relevant products
Burning Rock Dx Co. Ltd.
China · 1 relevant product
62 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 99 closest product alternatives
GESIM Gesellschaft für Silizium-Mikrosysteme mbH · Germany
Multiplexed microarray assay for simultaneous detection of multiple tumor markers in clinical samples. Enables comprehensive cancer biomarker profiling in a single test.
Guangdong Ascendas Genomics Technology Co., Ltd. · China
Multiplex PCR-based assay for simultaneous detection of multiple genetic targets using microfluidic technology. Provides cost-effective screening for genetic variations and pathogen identification.
Burning Rock Dx Co. Ltd. · China
Multiplex immunoassay platform for detecting circulating cancer biomarkers in blood samples. Facilitates early diagnosis and treatment response monitoring in oncology patients.
96 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products